1. According to House Bill 21, a prescription for a Schedule II opioid for acute pain may not exceed how many days?
A. 1
B. 3
C. 10
D. 15
2. A physician who prescribes controlled substances is required to take how many hours of continuing education focused on controlled substances every biennial renewal?
A. 1
B. 2
C. 3
D. 4
3. Which of the following is required to be reported in E-FORCSE each time a prescription for controlled substances is dispensed?
A. Patient gender
B. Drug NDC number
C. Pharmacy telephone number
D. A and B
4. Which of the following prescribers is exempt from reporting to E-FORCSE?
A. A prescriber working in the department of corrections
B. A prescriber dispensing a controlled substance to a 22-year-old patient
C. A prescriber dispensing a 7-day opioid prescription for “Acute Pain Exception”
D. All the above must report to E-FORCSE
5. A pharmacist has how long to report the dispensing of a controlled substance in E-FORCSE?
A. 1 year
B. 6 months
C. 30 days
D. 1 business day
6. Which of the following may indicate a fraudulent prescription?
A. A prescription for a controlled substance with a pink background color
B. A prescription written for 340 tablets of morphine sulfate for a new patient
C. Two different color inks were used on the prescription
D. All the above
7. Which of the following is a valid DEA number?
A. CS3456781
B. CA1234562
C. CB1388567
D. AH2235915
8. Before refusing to fill a prescription for a controlled substance, which of the following actions could a Florida pharmacist take to inquire about the validity of the prescription?
A. Consult E-FORCSE and the prescriber
B. Consult the prescriber and the patient
C. Consult E-FORCSE and the patient
D. Any the above are appropriate
9. Florida's standing order for naloxone authorizes pharmacists to dispense naloxone to which of the following?
A. Firefighters
B. Law enforcement
C. Emergency medical technicians
D. All the above
10. Which of the following naloxone dosage forms is approved to be dispensed by pharmacists for opioid overdose?
A. Oral
B. Intranasal
C. Inhalation
D. B and C
Evaluation Questions
11. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
12. To what extent did the program meet objective #2?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. To what extent did the program meet objective #3?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. To what extent did the program meet objective #4?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
16. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
17. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
18. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
19. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
20. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
21. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
22. Will the information presented cause you to change your practice?
A. Yes
B. No
23. Are you committed to making these changes?
A. Yes
B. No
24. As a result of this activity, did you learn something new?
A. Yes
B. No
25. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology
I. Specialty Pharmacy
J. Industry/Manufacturing
26. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20